Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
Recruiting
Observational Study
Abdominal Aortic Aneurysm
Primary Lung Cancer
Prevalence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- First Affiliated Hospital of Kunming Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients diagnosed with primary lung cancer through clinical or pathological examination
Exclusion Criteria:
* Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.
Contacts